BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//CiviCRM//NONSGML CiviEvent iCal//EN
X-WR-TIMEZONE:Europe/London
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20270204T103000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
UID:CiviCRM_EventID_2018_e86a4f28f24ec85011f2b11344e0bb4c@onenucleus.com
SUMMARY:Webinar - R&D Tax Relief in Life Sciences: Navigat
 ing the Challenges and Opportunities in 2027
X-ALT-DESC;FMTTYPE=text/html:<!DOCTYPE HTML PUBLIC
  "-//W3C//DTD HTML 3.2//EN"><html><body><p>R&D tax
  relief can provide valuable financial support to 
 life sciences and medtech businesses\, but navigat
 ing the rules and understanding how they apply to 
 complex research and development activities can be
  challenging. With significant changes to the R&D 
 tax relief regime in recent years and continued sc
 rutiny of claims\, understanding both the opportun
 ities and the requirements has never been more imp
 ortant.<br />\n From early-stage biotech companies
  to established medtech innovators\, businesses ac
 ross the sector face unique considerations when pr
 eparing R&D tax relief claims. Long development ti
 melines\, clinical research\, regulatory requireme
 nts\, collaborative projects and specialist subcon
 tracting arrangements can all add complexity to th
 e claims process.<br />\n As a life science busine
 ss looking ahead to 2027\, now is an important tim
 e to review your approach to R&D tax relief\, unde
 rstand the implications of the current landscape a
 nd ensure you are well positioned for future claim
 s. In this practical\, sector-focused webinar\, sp
 ecialist R&D tax relief consultancy <strong>Limest
 oneGrey</strong> will explore the key challenges\,
  considerations\, and opportunities for research-l
 ed businesses\, including:<br />\n •    <strong>Na
 vigating the R&D tax relief schemes</strong>: Unde
 rstanding the merged R&D scheme and Enhanced R&D I
 ntensive Support (ERIS)\, eligibility requirements
 \, and the potential financial and compliance impl
 ications of claiming under the wrong relief.<br />
 \n •    <strong>Understanding the impact of collab
 orative research</strong>: Exploring how research 
 partnerships\, CROs and subcontracted R&D activiti
 es can influence claim eligibility and entitlement
 .<br />\n •    <strong>Exploring changes to the ru
 les on funded R&D</strong>: Understanding how the 
 revised rules on funded projects affect your futur
 e claims.<br />\n •    <strong>Building robust sup
 porting evidence</strong>: The importance of effec
 tive record keeping throughout the R&D lifecycle\,
  particularly for complex\, multi-year research pr
 ojects.<br />\n •   <strong> Preparing a compliant
  and well-supported claim</strong>: Understanding 
 HMRC's Additional Information Form (AIF)\, technic
 al documentation requirements\, and the importance
  of presenting a clear\, defensible claim.<br />\n
  •   <strong> Recognising key deadlines and notifi
 cation requirements</strong>: Avoiding common proc
 edural pitfalls\, particularly for businesses clai
 ming for the first time or returning to R&D tax re
 lief after a period of not claiming.<br />\n <br /
 >\n <strong>Who should attend?</strong><br />\n Th
 is webinar is designed for founders\, CEOs\, CFOs\
 , finance professionals\, scientific leaders and R
 &D managers working across the life sciences\, bio
 technology\, pharmaceutical and medtech sectors.<b
 r />\n Whether you're an early-stage business cons
 idering R&D tax relief for the first time\, a grow
 ing company managing increasingly complex research
  arrangements\, or an established organisation loo
 king to strengthen its existing claims process\, t
 he session will provide practical\, sector-specifi
 c insights to help you approach R&D tax relief wit
 h greater confidence in 2027.</p>\n \n <p><strong>
 Complimentary R&D Tax Relief Health Check</strong>
 <br />\n Attendees will also have the opportunity 
 to access LimestoneGrey's complimentary R&D tax re
 lief health check. This provides an opportunity to
  discuss your business's individual circumstances\
 , review your current approach to claiming R&D tax
  relief and identify potential areas for improveme
 nt.</p>\n \n <p><strong>Meet the Speaker – Matthew
  Jones\, LimestoneGrey</strong><br />\n Matthew Jo
 nes is the Managing Director of LimestoneGrey\, a 
 regulated consultancy specialising in R&D tax reli
 ef. A dual-qualified Chartered Accountant and Char
 tered Tax Adviser\, Matthew brings a wealth of tec
 hnical expertise and experience supporting innovat
 ive businesses across the life sciences\, biotechn
 ology and medtech sectors. He understands the uniq
 ue challenges faced by research-led companies in t
 his space and the importance of navigating R&D tax
  relief with care and confidence.<br />\n Passiona
 te about making complex legislation accessible\, M
 atthew takes a practical and educational approach\
 , helping businesses understand their R&D tax reli
 ef opportunities\, navigate HMRC requirements and 
 build robust\, compliant claims.<br />\n <br />\n 
 <strong>This webinar is:<br />\n •    Free for emp
 loyees of One Nucleus member organisations\;<br />
 \n •    £75 + VAT for Non Members.</strong></p></b
 ody></html>
DESCRIPTION:R&D tax relief can provide valuable financial supp
 ort to life sciences and medtech businesses\, but 
 navigating the rules and understanding how they ap
 ply to complex research and development activities
  can be challenging. With significant changes to t
 he R&D tax relief regime in recent years and conti
 nued scrutiny of claims\, understanding both the o
 pportunities and the requirements has never been m
 ore important.\n \n From early-stage biotech compa
 nies to established medtech innovators\, businesse
 s across the sector face unique considerations whe
 n preparing R&D tax relief claims. Long developmen
 t timelines\, clinical research\, regulatory requi
 rements\, collaborative projects and specialist su
 bcontracting arrangements can all add complexity t
 o the claims process.\n \n As a life science busin
 ess looking ahead to 2027\, now is an important ti
 me to review your approach to R&D tax relief\, und
 erstand the implications of the current landscape 
 and ensure you are well positioned for future clai
 ms. In this practical\, sector-focused webinar\, s
 pecialist R&D tax relief consultancy LimestoneGrey
  will explore the key challenges\, considerations\
 , and opportunities for research-led businesses\, 
 including:\n \n •    Navigating the R&D tax relief
  schemes: Understanding the merged R&D scheme and 
 Enhanced R&D Intensive Support (ERIS)\, eligibilit
 y requirements\, and the potential financial and c
 ompliance implications of claiming under the wrong
  relief.\n \n •    Understanding the impact of col
 laborative research: Exploring how research partne
 rships\, CROs and subcontracted R&D activities can
  influence claim eligibility and entitlement.\n \n
  •    Exploring changes to the rules on funded R&D
 : Understanding how the revised rules on funded pr
 ojects affect your future claims.\n \n •    Buildi
 ng robust supporting evidence: The importance of e
 ffective record keeping throughout the R&D lifecyc
 le\, particularly for complex\, multi-year researc
 h projects.\n \n •    Preparing a compliant and we
 ll-supported claim: Understanding HMRC's Additiona
 l Information Form (AIF)\, technical documentation
  requirements\, and the importance of presenting a
  clear\, defensible claim.\n \n •    Recognising k
 ey deadlines and notification requirements: Avoidi
 ng common procedural pitfalls\, particularly for b
 usinesses claiming for the first time or returning
  to R&D tax relief after a period of not claiming.
 \n \n \n \n Who should attend?\n \n This webinar i
 s designed for founders\, CEOs\, CFOs\, finance pr
 ofessionals\, scientific leaders and R&D managers 
 working across the life sciences\, biotechnology\,
  pharmaceutical and medtech sectors.\n \n Whether 
 you're an early-stage business considering R&D tax
  relief for the first time\, a growing company man
 aging increasingly complex research arrangements\,
  or an established organisation looking to strengt
 hen its existing claims process\, the session will
  provide practical\, sector-specific insights to h
 elp you approach R&D tax relief with greater confi
 dence in 2027.\n \n \n \n Complimentary R&D Tax Re
 lief Health Check\n \n Attendees will also have th
 e opportunity to access LimestoneGrey's compliment
 ary R&D tax relief health check. This provides an 
 opportunity to discuss your business's individual 
 circumstances\, review your current approach to cl
 aiming R&D tax relief and identify potential areas
  for improvement.\n \n \n \n Meet the Speaker – Ma
 tthew Jones\, LimestoneGrey\n \n Matthew Jones is 
 the Managing Director of LimestoneGrey\, a regulat
 ed consultancy specialising in R&D tax relief. A d
 ual-qualified Chartered Accountant and Chartered T
 ax Adviser\, Matthew brings a wealth of technical 
 expertise and experience supporting innovative bus
 inesses across the life sciences\, biotechnology a
 nd medtech sectors. He understands the unique chal
 lenges faced by research-led companies in this spa
 ce and the importance of navigating R&D tax relief
  with care and confidence.\n \n Passionate about m
 aking complex legislation accessible\, Matthew tak
 es a practical and educational approach\, helping 
 businesses understand their R&D tax relief opportu
 nities\, navigate HMRC requirements and build robu
 st\, compliant claims.\n \n \n \n This webinar is:
 \n \n •    Free for employees of One Nucleus membe
 r organisations\;\n \n •    £75 + VAT for Non Memb
 ers.\n \n 
CATEGORIES:Not public
CALSCALE:GREGORIAN
DTSTAMP;TZID=Europe/London:20270204T103000
DTSTART;TZID=Europe/London:20270204T103000
DTEND;TZID=Europe/London:20270204T113000
LOCATION:ONLINE - webinar details will be sent to all deleg
 ates closer to the date of the event\n Cambridge\,
  \n United Kingdom\n 
URL:https://onenucleus.com/civicrm/event/info?reset=1&id=2018
END:VEVENT
END:VCALENDAR